Developing a center for respiratory and infectious disease research in Oklahoma
Official title: Oklahoma Center for Respiratory and Infectious Diseases
Funded at Oklahoma State University Stillwater · NIH-10881693 · Data updated 2026-11-12
This study is working to improve treatments and prevention for respiratory infections like COVID-19 and the flu, so patients can benefit from new medicines and vaccines developed through teamwork among different research centers.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma State University Stillwater NIH-funded |
| Lab location | 1 site (Stillwater, United States) |
| Project start | July 5, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,088,733 |
| NIH project number | 5P30GM149368-02 |
| Project ID | NIH-10881693 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals affected by respiratory infections, particularly those with COVID-19, influenza, or other related conditions.
✕Less likely to help
Patients with non-respiratory infectious diseases or those not affected by respiratory conditions may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the Oklahoma Center for Respiratory and Infectious Diseases (OCRID) to support innovative studies on respiratory infections, including COVID-19, influenza, and bacterial infections. The center collaborates with multiple institutions to conduct interdisciplinary projects that explore new therapeutics, vaccines, diagnostics, and disease mechanisms. Patients may benefit from advancements in treatment and prevention strategies developed through this collaborative research effort.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for respiratory infections, benefiting patients significantly.
How similar studies have gone: Previous phases of the OCRID have shown success in advancing respiratory infectious disease research, indicating a strong potential for continued impactful findings.
Where this research is happening
-
Oklahoma State University Stillwater
Stillwater, United States Active
Researchers
- Principal investigator: Liu, Lin — Oklahoma State University Stillwater
- Study coordinator: Liu, Lin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.